Anti-IgE (Omalizumab): A hope in the treatment of allergic diseases;Anti-IgE (omalizumab): Una esperanza en el tratamiento de las enfermedades alérgicas

Revista Clinica Espanola

Volumn 203, Issue 4, 2003, Pages 196-198

  Toledo, Ruben Félix ^b   Álvarez, J M Negro ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN E ANTIBODY; OMALIZUMAB; PLACEBO;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MECHANISM; HUMAN; IMMUNOTHERAPY;

EID: 0038147232     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13045541     Document Type: Article

References (13)

1. Corominas M. Tratamiento de las enfermedades alérgicas con anticuerpos monoclonales anti-IgE. Alergol Inmunol Clin 2001;16:39-45.
2. Presta LG, Lahr SJ, Shields RL, et al. Humanization of an antibody directed against IgE. J Immunol 1993;151:2623-32.
3. Easthope S, Jarvis B. Omalizumab. Drugs 2001;61(2):253-60.
4. Fahy JV, Fleming HE, Wong HH, et al. Inhibitory effects of an antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 1997;155:1828-34.
5. Fahy JV, Cockcroft DW, Boulet LP, et al. Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects. Am J. Respir Crit Care Med 1999;160:1023-7.
6. Milgrom H, Fick RB Jr, Su JQ, et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med 1999;341(26):1966-73
7. Milgrom H, Berger W, Nayak A, et al. Treatment of childhood asthma with anti-immunoglobutin E antibody. Pediatrics 2001;108(2):36.
8. Soler M, Matz J, Townley R, Buhl R, O'Brien J, Fox H, et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 2001;18(2):184-90.
9. Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108(2):184-90.
10. Casale TB, Bernstein IL, Busse WW, et al. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1997;100:110-21.
11. Casale TB, Condemi J, LaForce C, et al. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. JAMA 2001;286:2956-67.
12. Adelroth E, Rak S, Haahtela T, et al. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2000;106:253-9.
13. Kuehr J, Brauburger J, Zielen S, et al. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol 2002;109:274-80.